Streetbeat News

Earnings

AI

Significant investors have shown a mixed sentiment in C3.ai (NYSE:AI) options trading, with an equal split between bullish and bearish positions. The trading activity, highlighted by Benzinga, includes 12 transactions with a focus on a price range of $25.0 to $35.0 for C3.ai. The company, an enterprise AI solutions provider, has seen its stock price decrease by -2.06% to $28.5. Analysts have given mixed ratings, with an average target price of $28.0. The next earnings report is expected in 75 days.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:46 pm

ROKU

Deep-pocketed investors have shown a divided sentiment towards Roku (NASDAQ:ROKU), with options trading activity indicating both bullish and bearish positions. Benzinga's tracking revealed 12 significant options activities, with a price target range between $60.0 and $115.0. The trading volume and open interest suggest heightened interest in ROKU's options. Currently, ROKU's stock is slightly down by -0.25%, trading at $64.5, and might be considered oversold based on RSI readings. The anticipated earnings release is in 40 days, adding to the stock's watchfulness.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 3:31 pm

MSTR

MicroStrategy Incorporated (NASDAQ:MSTR) announced the pricing of its $525 million offering of 0.875% convertible senior notes due 2031, with an option to purchase up to an additional $78.75 million. The offering, intended for acquiring more Bitcoin and general corporate purposes, was upsized from $500 million. As of March 10, MicroStrategy held approximately 205,000 bitcoins. The company's stock has an average 1-year price target of $1,387.00, indicating a potential downside, with shares currently trading up 0.49% at $1,685.09.

Portfolio Pulse from Erica Kollmann

March 15, 2024 | 3:30 pm

SMR

NuScale Power Corp (NYSE:SMR) reported a Q4 FY23 sales increase of 35.3% year-on-year to $4.60 million, missing analyst estimates of $9.975 million. EPS was $(0.25), below the expected $(0.13). Fiscal 2023 revenue rose 93.2% to $22.8 million, but gross profit fell 14.2% to $3.8 million. The company's loss from operations widened to $(275.6) million from $(229.9) million the previous year. NuScale announced cost-efficiency actions expected to save $50 million-$60 million annually. Shares dropped 0.41% to $7.21.

Portfolio Pulse from Shivani Kumaresan

March 15, 2024 | 3:30 pm

BMY

GERN

Geron Corporation's (NASDAQ:GERN) shares traded lower despite the FDA's Oncologic Drugs Advisory Committee voting in favor of imetelstat for blood cancer. The panel supported the clinical benefit/risk profile of imetelstat, potentially Geron's first commercial treatment, targeting transfusion-dependent anemia in certain myelodysplastic syndromes patients. Imetelstat, competing with Bristol Myers Squibb's (NYSE:BMY) Reblozyl, is expected to generate $933 million in sales by 2029. Despite positive clinical trial results, FDA staff raised concerns about the treatment's risks versus benefits.

Portfolio Pulse from Vandana Singh

March 15, 2024 | 3:29 pm

JBL

QVAL

SRHQ

Jabil Inc (NYSE: JBL) reported a 16.8% year-on-year decrease in Q2 FY24 revenue, missing estimates with $6.77 billion. Adjusted EPS was $1.68, slightly above the consensus of $1.66. The company revised its FY24 revenue guidance downwards from $30.6 billion to $28.5 billion and expects core EPS of $8.40, down from $9.00+. JBL shares fell 16.20% to $123.44. Exposure to JBL can also be gained through SRHQ and QVAL ETFs.

Portfolio Pulse from Anusuya Lahiri

March 15, 2024 | 3:26 pm

ADBE

MSFT

NVDA

The article discusses the impact of a $5 trillion quadruple witching event on the stock market, highlighting Microsoft's breakout amidst NVIDIA's pullback, and Adobe's stock fall due to AI competition. It also covers Japan's wage negotiations potentially affecting the Bank of Japan's interest rate policy, early trade money flows in major tech stocks and ETFs, and Bitcoin whales liquidating $500M. The article advises investors on protection strategies amidst market volatility.

Portfolio Pulse from The Arora Report

March 15, 2024 | 3:22 pm

BKE

Buckle's shares have seen an increase following the announcement of their fourth-quarter earnings per share (EPS), which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 3:22 pm

CDLX

Cardlytics, Inc. (NASDAQ:CDLX) shares surged after reporting Q4 earnings of 14 cents per share, beating estimates of 12 cents, and issuing Q1 revenue guidance between $70 million and $73 million, surpassing the $66.46 million estimate. Despite a slight miss in Q4 sales, the company's year-over-year growth and positive outlook, supported by a Buy rating and raised price target from Needham analyst Kyle Peterson, have contributed to the stock's upward movement.

Portfolio Pulse from Erica Kollmann

March 15, 2024 | 3:17 pm

GRPN

Groupon's stock initially rose after the company reported its Q4 financial results but has since experienced a decline.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 3:12 pm